Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.001
Buy
RSI(14)
66.276
Neutral
STOCH(KDJ)(9,3,3)
73.110
Sell
ATR(14)
2.694
High Vlolatility
CCI(14)
101.477
Buy
Williams %R
28.075
Buy
TRIX(12,20)
1.272
Sell
StochRSI(14)
11.848
Sell
Search
Eton Pharmaceuticals Inc
ETONAdd to Watchlist
46.420USD
-2.610-5.32%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.27BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.32%
5 Days
+8.99%
1 Month
+23.79%
6 Months
+206.00%
Year to Date
+174.51%
1 Year
+228.52%
Key Figures
49.090Open
49.090High
484.79KVolume
LossP/E TTM
24.46P/E Dynamic
--Dividend TTM
1.77%Turnover Ratio
49.030Prev. Close
46.010Low
16.49MTurnover
LossP/E Static
41.48P/B
0.00%Div Yield TTM
-1.62%ROA
35.66052wk High
0.80Volume Ratio
-3.82MNet Profit
27.36MShares
-0.0556EPS TTM
0.88Beta
-5.36%ROE
13.08552wk Low
6.28%Amplitude
60.72%Gross Margin
1.27BMarket Cap
8.99Reward/Risk
3.22%Risk Rate
TradingKey Stock Score of Eton Pharmaceuticals Inc
Currency: USD Updated: 2026-07-31Key Insights
Eton Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 39 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 54.75.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Eton Pharmaceuticals Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Eton Pharmaceuticals Inc Highlights
StrengthsRisks
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 152.67% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 79.95M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 79.95M.
Undervalued
The company’s latest PE is -835.34, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 15.99M shares, decreasing 18.71% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 15.71K shares of this stock.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
54.750
Target Price
+17.94%
Upside Space
Eton Pharmaceuticals Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
4
analysts
Buy
Current Rating
54.750
Target Price
+17.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Eton Pharmaceuticals Inc
ETON
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
46.510
Sell
MA10
44.713
Buy
MA20
41.293
Buy
MA50
35.965
Buy
MA100
30.561
Buy
MA200
23.651
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Eton Pharmaceuticals Inc Info
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.
Ticker SymbolETON
CompanyEton Pharmaceuticals Inc
CEOBrynjelsen (Sean E)
Websitehttps://etonpharma.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52778.700
+400.700 (+0.77%)
28516.900
+356.000 (+1.26%)
7535.200
+60.100 (+0.80%)
14586.000
-163.000 (-1.10%)
63643.000
+791.000 (+1.26%)
6406.300
+40.900 (+0.64%)
78.712
-7.222 (-8.40%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4065.660
+24.230 (+0.60%)
FAQs
What is the current price of Eton Pharmaceuticals Inc (ETON)?
The current price of Eton Pharmaceuticals Inc (ETON) is 46.42.
What is the symbol of Eton Pharmaceuticals Inc?
The ticker symbol of Eton Pharmaceuticals Inc is ETON.
What is the 52-week high of Eton Pharmaceuticals Inc?
The 52-week high of Eton Pharmaceuticals Inc is 35.66.
What is the 52-week low of Eton Pharmaceuticals Inc?
The 52-week low of Eton Pharmaceuticals Inc is 13.09.
What is the market capitalization of Eton Pharmaceuticals Inc?
The market capitalization of Eton Pharmaceuticals Inc is 1.27B.
Is Eton Pharmaceuticals Inc (ETON) currently rated as Buy, Hold, or Sell?
According to analysts, Eton Pharmaceuticals Inc (ETON) has an overall rating of Buy, with a price target of 54.75.
What is the Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON)?
The Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON) is -0.17.